By Sruthi Shankar
(Reuters) -UK's FTSE 100 edged up on Monday as gains in drugmaker AstraZeneca (NASDAQ:AZN) and consumer stocks relieved pressure from mining and oil heavyweights after data showed China's economy unexpectedly slowed last month.
The blue-chip FTSE 100 added 0.2% to hold near 10-week highs, while the midcap FTSE 250 index inched up 0.1%.
Investors are awaiting the UK employment report as well as consumer prices data later this week to gauge the state of the labour market and inflation.
The data could offer clues on whether the Bank of England opts for a second consecutive 50-basis-point-rate hike at its September meeting.
The mood was dull in Asian and European stock markets, with investors turning to defensive sectors such as healthcare and consumer staples amid worries about the health of the world's second-largest economy.
AstraZeneca gained 2.6% after the drugmaker said its cancer drug, Enhertu, developed with Japan's Daiichi Sankyo delayed the progression of a form of advanced breast cancer in previously treated patients.
Oil major Shell (LON:RDSa) and miners Rio Tinto (LON:RIO) and Anglo American (LON:AAL) slipped, in tandem with weaker commodity prices, after the release of the China data. [O/R] [MET/L]
The FTSE 100 has outperformed its global peers this year due to its large exposure to commodity stocks that have surged on the back of a jump in oil and metal prices. A weakening pound has also boosted dollar earners in the index.
"Whether this trend will continue ultimately hinges on the outlook for global energy stocks relative to the broad market," BCA Research analysts wrote in a note.
The FTSE 100 is up nearly 2% so far this year, while the MSCI world equities index has shed almost 13%.
"Our energy strategists remain bullish on oil. Their expectation that Brent will breach $110/bbl in Q4 and average $117/bbl in 2023 suggests that an overweight on the energy sector – and by extension UK equities – remains appropriate."